SD Biosensor, Limited Possibility of Sharp Sales Decline

[Asia Economy Reporter Hyungsoo Park] Heungkuk Securities analyzed on the 4th that the possibility of a rapid decline in sales of SD Biosensor is not high.

SD Biosensor is a specialized in vitro diagnostics company that develops and sells products in various in vitro diagnostic fields such as immunochemical diagnostics, molecular diagnostics, point-of-care testing, and self-blood glucose monitoring.

Choi Jong-kyung, a researcher at Heungkuk Securities, explained, "Standard Q sales increased from about 6.4 billion KRW in 2019 to 1.412 trillion KRW in 2020," adding, "Although there were already more than 50 disease diagnostic products, the COVID-19 pandemic served as an opportunity to recognize the technology and product value."

He continued, "It can diagnose diseases quickly and easily, with high sensitivity and specificity," and added, "A new Standard M point-of-care molecular diagnostic device is scheduled to be launched in August this year."

He evaluated, "Existing molecular diagnostic devices have the disadvantage of taking a long time for diagnosis," and "SD Biosensor's products are competitive because they can diagnose quickly."

Researcher Choi predicted, "The new product will act as a new performance improvement factor," and "Since a supply contract for Standard Q with Roche is signed until May next year, the possibility of a rapid decline in sales this year will be limited."

The expected IPO price range for SD Biosensor is 45,000 to 52,000 KRW, and the estimated market capitalization is 4.5726 trillion to 5.2839 trillion KRW. The estimated public offering amount is 373.3 billion to 431.3 billion KRW. The proceeds from the public offering will be used for facility funds and operating funds related to the construction of a factory campus and for establishing overseas subsidiaries. The scheduled listing date is in July, and the demand forecast for the new listing will be conducted over two days starting from the 5th.

This content was produced with the assistance of AI translation services.